Our one team philosophy guides us and our partners toward a shared vision: eliminating cardiovascular and metabolic diseases so all people can lead happier, healthier, longer lives.
At Janssen, we believe that true innovation comes from the continually expanding global “think tank” of talented and passionate pioneers. We pursue new perspectives and innovative ideas wherever they are—inside or outside our company—and work with the best scientific minds in cardiovascular and metabolism today.
We focus our investment where we see an area of expertise and the potential for innovation. As an organization, we've committed to focusing on select disease areas where we are developing deep expertise. When a groundbreaking idea emerges, we are poised to rapidly move forward.
Our focus in cardiovascular and metabolism matches an entrepreneurial biotech spirit within a global pharmaceutical framework. We are active collaborators and project champions, committed to giving projects the time and attention they need to be successful.
We aim to be the partner of choice whether joining with academia, advancing promising compounds and working with talented researchers, or forming research and development and business alliances with companies that possess complementary strengths.
Our capabilities include state-of-the-art discovery, biomarkers, companion diagnostics and global development programs of biologics and small molecules, and strong commercialization entities that market our products in more than 175 countries.
We engage in diverse and varied partnerships at all levels of the discovery and development process through our regional Innovation Centers and Business Development group.
These teams of scientific, transaction and alliance management experts lead the identification, evaluation and execution of agreements relating to compounds (early-stage discovery programs through to marketed products) and technologies. Together, our Innovation Centers and Business Development teams drive the strategic focus and manage our external collaborations for mutual long-term success with academic institutions, venture investors and biotech and large pharmaceutical companies alike.
At Janssen our people ensure that each partnership and collaborative effort is driven by an entrepreneurial spirit coupled with dedication to cutting-edge technology and scientific leadership in cardiovascular and metabolics areas. As a team, we have the commitment and focus to bring innovation to life. As individuals, we are passionate about advancing solutions for patients.
If you have a licensing candidate or program idea that you feel may be of interest to Janssen, we invite you to submit this idea on the contact form located here.
Following submission, your idea will be screened for suitability for our business objectives. Successful screening leads to evaluation by a team of cross-functional experts. After a positive evaluation, a broader team performs due diligence, which, if successful, leads to a recommendation to proceed.